Brain Blood Flow Changes Elicited by Oxytocin in Volunteers With and Without Schizophrenia
Status:
Withdrawn
Trial end date:
2013-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess how oxytocin delivered intranasally changes regional
brain blood flow measured by positron emission tomography (PET) in conjunction with oxygen-15
labeled water in persons with schizophrenia. The objective is to better our understanding of
oxytocin's role in the modulation of social judgment in schizophrenia and provide more
information as to potential uses of oxytocin or a similar drug analog in treating certain
features of schizophrenia and other neuropsychiatric disorders.
Phase:
N/A
Details
Lead Sponsor:
University of Maryland University of Maryland, Baltimore